Position
Chief Executive Officer
Company
Illuminare Biotechnologies
New YorkBiotechnologyHealth CareMedicalTherapeuticsDescription
Illuminare Biotechnologies announced the appointment of Brian Longstreet as Chief Executive Officer, effective June 1, 2026. With 30 years of experience in pharmaceuticals and biotechnology, Brian is expected to lead the company through its crucial phase of clinical development and commercialization.
Quick answer
Illuminare Biotechnologies Appoints Brian Longstreet as Chief Executive Officer (July 14, 2026). Illuminare Biotechnologies is based in New York, New York, United States.
- Who is the new Chief Executive Officer at Illuminare Biotechnologies?
- Illuminare Biotechnologies named Brian Longstreet Chief Executive Officer, announced July 14, 2026.
- What did Illuminare Biotechnologies announce on July 14, 2026?
- Illuminare Biotechnologies announced the appointment of Brian Longstreet as Chief Executive Officer, effective June 1, 2026. With 30 years of experience in pharmaceuticals and biotechnology, Brian is expected to lead the company through its crucial phase of clinical development and commercialization.
- What does Illuminare Biotechnologies do?
- Illuminare Biotechnologies is a clinical-stage company focused on intraoperative nerve visualization to reduce the risk of nerve damage.
- Where is Illuminare Biotechnologies based?
- Illuminare Biotechnologies is based in New York, New York, United States.
- Which similar companies made leadership changes around the same time?
- Immunocine Cancer Center (July 7, 2026), Ascidian Therapeutics (July 21, 2026), Harmony Biosciences (July 23, 2026) and Imugene (July 27, 2026) also announced leadership changes within 45 days of Illuminare Biotechnologies.
Source: Fundz verified event record.
Other recent leadership changes in Medical and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Immunocine Cancer Center Appoints Vita S. Salsman as Executive Director (July 7, 2026)
- Ascidian Therapeutics Appoints Daniel Rosan as President (July 21, 2026)
- Harmony Biosciences Appoints Stephen Mollichella as Interim CFO (July 23, 2026)
- Imugene Limited Announces Resignation of CEO Leslie Chong Effective Immediately (July 27, 2026)
- Aqua Medical Appoints Robert Haggerty as President and Chief Executive Officer (August 4, 2026)
- First Ascent Biomedical Appoints Raymond Rodriguez-Torres as President (June 22, 2026)
Who to call at Illuminare Biotechnologies, and when
A new leader at Illuminare Biotechnologies brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Illuminare Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Illuminare Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Illuminare Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Illuminare Biotechnologies changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Illuminare Biotechnologies changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.